These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP. Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387 [Abstract] [Full Text] [Related]
4. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. Cavill D, Waterman SA, Gordon TP. Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012 [Abstract] [Full Text] [Related]
6. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Cavill D, Waterman SA, Gordon TP. Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576 [Abstract] [Full Text] [Related]
11. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. Koo NY, Li J, Hwang SM, Choi SY, Lee SJ, Oh SB, Kim JS, Lee EB, Song YW, Park K. Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835 [Abstract] [Full Text] [Related]
13. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609 [Abstract] [Full Text] [Related]
14. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis. Iizuka M, Wakamatsu E, Tsuboi H, Nakamura Y, Hayashi T, Matsui M, Goto D, Ito S, Matsumoto I, Sumida T. J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316 [Abstract] [Full Text] [Related]
15. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. Gao J, Killedar S, Cornelius JG, Nguyen C, Cha S, Peck AB. J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168 [Abstract] [Full Text] [Related]
16. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjögren's syndrome. Park K, Haberberger RV, Gordon TP, Jackson MW. Arthritis Rheum; 2011 May; 63(5):1426-34. PubMed ID: 21312189 [Abstract] [Full Text] [Related]
18. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors. Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K. Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887 [Abstract] [Full Text] [Related]
19. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome. Sumida T, Tsuboi H, Iizuka M, Nakamura Y, Matsumoto I. Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524 [Abstract] [Full Text] [Related]